View as an RSS Feed
View Ron Sommer's Articles BY TICKER:
AAN, AAP, ABC, ADP, ALK, AMSG, ANN, AZN, BA, BAX, BIIB, CEL, CHKP, CLB, CLW, CMI, CMTL, COV, CRUS, CSCO, CTB, CVD, DAKT, DDS, DELL, DOV, DOX, EAT, ENDP, EZPW, FRD, FRX, FUQI, GME, GRA, GRMN, GTAT, HRB, HRL, HRS, HUM, HWKN, IDCC, ITRN, KLIC, LLY, MCRS, MDP, MNDO, MSFT, MZOR, NFLX, NSR, QCOM, RS, RTN, SHPG, SNDK, SNI, SNN, SORL, SPY, STE, SWHC, SWM, SYK, SYMC, TECH, TEO, TEVA, TKC, TNH, TSCO, VCI, WCG, WDC, WLP, XOM
Dillard's - An Unappreciated Opportunity
- Positive Comparable Store Sales.
- Strong EBITDA Growth Over The Past Five Years.
- Improving Profitability Both On Gross Margin and Expense Control.
Where's The Beef? Consolidation In The Meat Processing Industry
- Acquisitions are being made at record premium levels.
- There is a shrinking pool of potential acquisition targets.
- SAFM is undervalued and a potential target.
Aaron's Inc. As An Opportunistic Investment
- The company has attractive fundamentals. It is profitable, generates significant free cash flow and has a solid balance sheet.
- The company is, by some metrics, undervalued.
- The company is in play and has an offer from Vintage Capital.
- Cirrus Logic: Trap Or Opportunity?
- A Long-Term View Of Cellcom Israel
- Mazor Robotics And The Medical Revolution
- Scripps Networks Revisited
- The Next Network Acquisition Target
- Opportunities In Home Healthcare
- Gloomy Prospects For Medical Device Companies
- The Post-Secondary Education Market
- Dover Corporation - A Quantitative Analysis
- AmerisourceBergen Beats The Competition
- Teva Pharmaceuticals Is A Bitter Pill To Swallow
- Israel - A Standout Among The OECD Economies
- Ituran Location And Control: A Leader In Auto Recovery Services
- Alaska Air Group Still Undervalued
- Boeing Is A High Flyer
- Given Imaging Up For Grabs
- Valassis Communications - A Small Cap With Potential
- Symantec Restructures And Investors Will Benefit
- Creative Destruction And The Pharmaceutical Industry
- Teva Pharmaceutical: A Company In Transition
- Schweitzer-Mauduit: An Overlooked Small-Cap Gem
- Amdocs Offers Long-Term Opportunity
- A Bullish Case For Smith & Wesson
- Dillard's: A Great Retail Sector Opportunity
- 2 Deep Value Oil Refiners
- H&R Block: A Risky Opportunity
- Have Exxon Mobil's Shares Peaked?
- Harris Corp. - Undervalued And Underrated
- AstraZeneca Will Rise Again